Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases.
第一作者:
Monica F,Chen
第一单位:
Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
作者:
医学主题词
人类(Humans);肺肿瘤(Lung Neoplasms);女(雌)性(Female);男(雄)性(Male);中年人(Middle Aged);老年人(Aged);脑肿瘤(Brain Neoplasms);突变(Mutation);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);成年人(Adult);喹啉类(Quinolines);脑膜肿瘤(Meningeal Neoplasms);脑膜癌病(Meningeal Carcinomatosis);老年人, 80以上(Aged, 80 and over);存活率(Survival Rate)
DOI
10.1016/j.jtho.2025.10.012
PMID
41139066
发布时间
2026-05-06
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



